Search Results - Tsai, F.Y.-C.

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations

    A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high in... by Rodon, J., Rodriguez, E., Maitland, M.L., Tsai, F.Y.-C., Socinski, M.A., Berlin, J.D., Thomas, J.S., Al Baghdadi, T., Wang, I.-M., Guo, C., Golmakani, M., Clark, L.N., Gazdoiu, M., Li, M., Tolcher, A.W.

    Published in ESMO open
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: